Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer
Objective. Phosphoglycerate kinase 1 (PGK1) is an essential enzyme in the process of glycolysis and mitochondrial metabolism. Herein, we conducted a systematic analysis to uncover the clinical implication of PGK1 deregulation in breast cancer. Methods. Expression pattern and prognostic significance...
Guardado en:
Autores principales: | Liangdong Li, Yang Bai, Yang Gao, Deheng Li, Lei Chen, Changshuai Zhou, Mingtao Feng, Xin Chen, Wei Jin, Yiqun Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec6f52d8174349018c3b6b5452272c24 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth
por: Hao Nie, et al.
Publicado: (2020) -
Identification of Immune-Related Genes Associated With Bladder Cancer Based on Immunological Characteristics and Their Correlation With the Prognosis
por: Zhen Kang, et al.
Publicado: (2021) -
High Moesin Expression Is a Predictor of Poor Prognosis of Breast Cancer: Evidence From a Systematic Review With Meta-Analysis
por: Xiaoli Hu, et al.
Publicado: (2021) -
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?
por: Satoshi Sakaue, et al.
Publicado: (2017) -
The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
por: Kai Li, et al.
Publicado: (2021)